MAGT1 Gene Immunodeficiency X-linked with magnesium defect Epstein-Barr virus infection and neoplasia Genetic Test
Test Name: MAGT1 Gene Immunodeficiency X-linked with magnesium defect Epstein-Barr virus infection and neoplasia Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Test type: Hepatology Nephrology Endocrinology Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for MAGT1 Gene Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MAGT1 Gene Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia NGS Genetic DNA Test gene MAGT1
Test Details: MAGT1 gene immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus (EBV) infection, and neoplasia is a rare genetic disorder. It is caused by mutations in the MAGT1 gene, which is located on the X chromosome. This condition is characterized by a range of symptoms and complications. Individuals with this disorder have impaired immune function, making them more susceptible to infections, particularly with EBV. They also have a magnesium transport defect, leading to low levels of magnesium in their cells. The most common manifestation of this condition is a severe form of EBV infection, which can cause recurrent infections, chronic active EBV infection, or even develop into lymphoma or other malignancies.
NGS genetic testing, which stands for Next-Generation Sequencing, is a type of genetic test that can be used to identify mutations in the MAGT1 gene. This test analyzes the individual’s DNA to detect any changes or abnormalities in the gene sequence. By identifying the specific mutation in the MAGT1 gene, NGS genetic testing can provide a definitive diagnosis for individuals suspected of having this disorder. It can also help determine the risk of developing complications associated with the condition.
Genetic testing is typically recommended for individuals with a family history of the disorder, those with symptoms suggestive of the condition, or those who have had recurrent or severe EBV infections. Early diagnosis through genetic testing can be beneficial in managing the condition and preventing complications. Treatment options may include antiviral medications, immune system support, and magnesium supplementation. It is important to consult with a genetic counselor or healthcare professional to discuss the benefits, limitations, and implications of genetic testing before undergoing the test.
Test Name | MAGT1 Gene Immunodeficiency X-linked with magnesium defect Epstein-Barr virus infection and neoplasia Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hepatology Nephrology Endocrinology Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MAGT1 Gene Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MAGT1 Gene Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia NGS Genetic DNA Test gene MAGT1 |
Test Details |
MAGT1 gene immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus (EBV) infection, and neoplasia is a rare genetic disorder. It is caused by mutations in the MAGT1 gene, which is located on the X chromosome. This condition is characterized by a range of symptoms and complications. Individuals with this disorder have impaired immune function, making them more susceptible to infections, particularly with EBV. They also have a magnesium transport defect, leading to low levels of magnesium in their cells. The most common manifestation of this condition is a severe form of EBV infection, which can cause recurrent infections, chronic active EBV infection, or even develop into lymphoma or other malignancies. NGS genetic testing, which stands for Next-Generation Sequencing, is a type of genetic test that can be used to identify mutations in the MAGT1 gene. This test analyzes the individual’s DNA to detect any changes or abnormalities in the gene sequence. By identifying the specific mutation in the MAGT1 gene, NGS genetic testing can provide a definitive diagnosis for individuals suspected of having this disorder. It can also help determine the risk of developing complications associated with the condition. Genetic testing is typically recommended for individuals with a family history of the disorder, those with symptoms suggestive of the condition, or those who have had recurrent or severe EBV infections. Early diagnosis through genetic testing can be beneficial in managing the condition and preventing complications. Treatment options may include antiviral medications, immune system support, and magnesium supplementation. It is important to consult with a genetic counselor or healthcare professional to discuss the benefits, limitations, and implications of genetic testing before undergoing the test. |